Ling‐Chang Tong

594 total citations
8 papers, 484 citations indexed

About

Ling‐Chang Tong is a scholar working on Molecular Biology, Neurology and Pharmacology. According to data from OpenAlex, Ling‐Chang Tong has authored 8 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Neurology and 2 papers in Pharmacology. Recurrent topics in Ling‐Chang Tong's work include Barrier Structure and Function Studies (2 papers), Cell Adhesion Molecules Research (2 papers) and Caveolin-1 and cellular processes (2 papers). Ling‐Chang Tong is often cited by papers focused on Barrier Structure and Function Studies (2 papers), Cell Adhesion Molecules Research (2 papers) and Caveolin-1 and cellular processes (2 papers). Ling‐Chang Tong collaborates with scholars based in China. Ling‐Chang Tong's co-authors include Zhibin Wang, Wei‐Ye Liu, Lichao Zhang, Sheng Sun, Ding‐Feng Su, Yue Wang, Ling Li, Ling Li, Su Zhang and Yue Wang and has published in prestigious journals such as Scientific Reports, Frontiers in Pharmacology and International Immunopharmacology.

In The Last Decade

Ling‐Chang Tong

8 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling‐Chang Tong China 7 261 76 68 66 61 8 484
Yanfang Wu China 13 229 0.9× 60 0.8× 43 0.6× 33 0.5× 29 0.5× 39 478
Chenyang Li China 12 195 0.7× 66 0.9× 46 0.7× 58 0.9× 26 0.4× 25 521
Tangyou Mao China 16 408 1.6× 160 2.1× 60 0.9× 77 1.2× 34 0.6× 42 688
Xin Shao China 6 192 0.7× 54 0.7× 27 0.4× 53 0.8× 36 0.6× 10 365
Ziwen Yuan China 13 364 1.4× 106 1.4× 43 0.6× 36 0.5× 26 0.4× 25 547
Caigui Xiang China 10 247 0.9× 90 1.2× 47 0.7× 179 2.7× 38 0.6× 16 520
Minyao Li China 11 228 0.9× 110 1.4× 38 0.6× 56 0.8× 21 0.3× 20 442
Yue Wan China 11 314 1.2× 87 1.1× 45 0.7× 73 1.1× 14 0.2× 22 506
Sijing Dong China 10 287 1.1× 79 1.0× 81 1.2× 40 0.6× 12 0.2× 14 514
Meizhou Huang China 16 233 0.9× 44 0.6× 52 0.8× 59 0.9× 16 0.3× 31 569

Countries citing papers authored by Ling‐Chang Tong

Since Specialization
Citations

This map shows the geographic impact of Ling‐Chang Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Chang Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Chang Tong more than expected).

Fields of papers citing papers by Ling‐Chang Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Chang Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Chang Tong. The network helps show where Ling‐Chang Tong may publish in the future.

Co-authorship network of co-authors of Ling‐Chang Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Ling‐Chang Tong. A scholar is included among the top collaborators of Ling‐Chang Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling‐Chang Tong. Ling‐Chang Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Tong, Ling‐Chang, Zhibin Wang, Jiaqi Zhang, et al.. (2021). Swiprosin-1 deficiency in macrophages alleviated atherogenesis. Cell Death Discovery. 7(1). 344–344. 2 indexed citations
2.
Wang, Zhibin, Yue Wang, Wei‐Ye Liu, et al.. (2018). Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy. Cellular Physiology and Biochemistry. 45(3). 899–916. 31 indexed citations
3.
Zhang, Lichao, Yue Wang, Ling‐Chang Tong, et al.. (2017). Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress. Experimental and Therapeutic Medicine. 13(6). 3374–3382. 79 indexed citations
4.
Wang, Zhibin, Su Zhang, Ya Li, et al.. (2017). LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1. Acta Pharmacologica Sinica. 38(7). 1009–1023. 20 indexed citations
5.
Tu, Ye, Lichao Zhang, Ling‐Chang Tong, et al.. (2017). EFhd2/swiprosin-1 regulates LPS-induced macrophage recruitment via enhancing actin polymerization and cell migration. International Immunopharmacology. 55. 263–271. 24 indexed citations
6.
Wang, Zhibin, Ping Han, Ling‐Chang Tong, et al.. (2017). Low level of swiprosin-1/EFhd2 in vestibular nuclei of spontaneously hypersensitive motion sickness mice. Scientific Reports. 7(1). 40986–40986. 10 indexed citations
7.
Tong, Ling‐Chang, Yue Wang, Zhibin Wang, et al.. (2016). Propionate Ameliorates Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Reducing Inflammation and Oxidative Stress. Frontiers in Pharmacology. 7. 253–253. 264 indexed citations
8.
Liu, Wei‐Ye, Zhibin Wang, Yue Wang, et al.. (2015). Increasing the Permeability of the Blood–brain Barrier in Three Different Models in vivo. CNS Neuroscience & Therapeutics. 21(7). 568–574. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026